CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma.
Yang G, Wang Y, Xiao J, Zhao F, Qiu J, Liu Y, Chen G, Cao Z, You L, Zheng L, Zhang T, Zhao Y.
Yang G, et al. Among authors: liu y.
Cell Oncol (Dordr). 2021 Apr;44(2):345-355. doi: 10.1007/s13402-020-00569-7. Epub 2020 Oct 30.
Cell Oncol (Dordr). 2021.
PMID: 33125631